Remora Capital

About

Remora Biotech | Building High-Value Biotherapy Companies Across Immunotherapy, Vectorized and Cell Gene Therapy Turning science into life-changing biotherapies We accelerate the design of innovative, competitive biotherapies to increase their likelihood of success. A proven track record in biotherapy innovation We combine scientific excellence with entrepreneurial execution to advance a diversified portfolio of biotherapy companies. Our company improves early innovation, de-risks development, and creates repeatable value for partners, patients, and investors. Our approach Regenerative Aesthetics Biotherapies that repair, rejuvenate, and enhance tissues, enabling differentiated, fast-moving innovations in regenerative and aesthetic medicine. An emerging field at the doorstep of a revolution in healthy ageing. Immunotherapy Multifunctional immune modulators designed to improve efficacy, safety, and cost-efficiency of next-generation treatments for cancer and immune disease. The way forward for scaling immunotherapy’s success. Vectorized Targeting proven therapeutic payloads using antibody vectors. The long-awaited solution for precision chemotherapy and radiotherapy with less adverse effects and better efficacy. Cell Gene Therapy Reprograming patient’s own cells to treat cancer, autoimmune diseases and beyond. The ultimate frontier in medicine. A diversified portfolio of Remora companies Our portfolio spans multiple biotherapy companies with rigorous science and strong leaders

Key Contact

Geographic Focus